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Abstract
Background
Arboviruses have overlapping geographical distributions and can cause symptoms that
coincide with more common infections. Therefore, arbovirus infections are often neglected
by travel diagnostics. Here, we assessed the potential of syndrome-based approaches for
diagnosis and surveillance of neglected arboviral diseases in returning travelers.
Method
To map the patients high at risk of missed clinical arboviral infections we compared the
quantity of all arboviral diagnostic requests by physicians in the Netherlands, from 2009
through 2013, with a literature-based assessment of the travelers’ likely exposure to an
arbovirus.
Results
2153 patients, with travel and clinical history were evaluated. The diagnostic assay for den-
gue virus (DENV) was the most commonly requested (86%). Of travelers returning from
Southeast Asia with symptoms compatible with chikungunya virus (CHIKV), only 55% were
tested. For travelers in Europe, arbovirus diagnostics were rarely requested. Over all, diag-
nostics for most arboviruses were requested only on severe clinical presentation.
Conclusion
Travel destination and syndrome were used inconsistently for triage of diagnostics, likely
resulting in vast under-diagnosis of arboviral infections of public health significance. This
study shows the need for more awareness among physicians and standardization of syn-
dromic diagnostic algorithms.
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Author Summary
Physicians attending travelers with particular symptoms often neglect those infections
that are transmitted by arthropods like ticks and mosquitoes (arboviruses) or don’t test for
the appropriate arboviruses. This is because arboviruses cause symptoms that are similar
to more common infections and because there is a geographical overlap in the arbovirus
infections that people have a large chance of being infected with. We compared the
amount of times that Dutch physicians had patients tested for arboviral infections with the
likelihood that Dutch travelers would be exposed to particular arboviruses. Whereas
research and diagnostics generally focus on only one virus, our study was uniquely com-
prehensive and systematic in that it analyzed multiple viruses simultaneously on the basis
of a unique national database. The research shows that the current viruses travelers are
tested for is incomplete and likely many more people carry these kinds of diseases than are
diagnosed. As these diseases pose potential public health threats, physicians should be
more aware of the diseases that travelers could be infected with, and protocols are needed
regarding what infectious diseases physicians should check for when patients present with
particular symptoms.
Introduction
Globalization has resulted in a steep increase in travel and trade.[1, 2] In recent decades it has
contributed to the spread of diseases that traditionally emerged only regionally but now
threaten populations across the globe, stressing the need for global health surveillance.[1, 2]
Among these emerging threats, arboviruses form a unique group, with a large public health
impact in endemic countries, a tendency to expand their geographical distribution through
trade and travelers, and colonize previously unaffected areas. Due to their vector-borne and
often zoonotic nature, they require targeted surveillance and control schemes. This require-
ment is particularly relevant when evaluating symptoms of illness in travelers. Of all those
returning from developing, tropical, or subtropical countries, 8% require medical care on
return.[3] For those returning from Africa and Southeast Asia, fever is the most common rea-
son for seeking medical care; for travelers returning from the Caribbean and South America,
rash is the most common reason. Around 50% of the cases remain undiagnosed in clinics
focused on travel medicine, and this percentage is likely higher in less specialized clinics.[3]
The traveler’s personal physician is therefore an important link in ongoing arbovirus surveil-
lance in travelers and the gate-keepers of disease detection.
Correct diagnosis of arbovirus infections in travelers is challenging. Arboviruses have over-
lapping geographical distributions and cause symptoms that coincide with more common
infections.[4] If general practitioners consider an arbovirus infection in their differential diag-
nosis, they commonly test for the best known arboviral disease, Dengue virus (DENV). Labora-
tory diagnostics for travelers are largely based on serologic testing, since viremia is short-lived
and has often already dropped to undetectable levels when severe symptoms appear and diag-
nostics are performed.[5, 6] The use of serologic results for arbovirus diagnosis and surveil-
lance requires careful evaluation due to cross-reactivity of antibodies to related viruses.[7]
Also, several vaccines, notably for Yellow fever, Tick-borne encephalitis and Japanese encepha-
litis, can cause false-positive serological tests.[7]
For these reasons, arbovirus illness is under-diagnosed, as evidenced by studies of unex-
plained illness in returned travelers.[8–10] A potential solution would be the development of
syndromic arboviral disease detection methods that cover the most common arboviruses and
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simultaneously provide surveillance information.[11] Here we aimed to assess the potential
added value of syndrome-based approaches for diagnosis and surveillance of neglected arbo-
viral diseases in returning Dutch travelers.
Methods
To map the patients high at risk of missed clinical arboviral infections in returned Dutch trav-
elers, we compared the quantity and quality of all arboviral diagnostic requests by Dutch physi-
cians, from 2009 through 2013, with a previously extensive literature-based assessment of
travelers’ likely infection with an arbovirus.[4] The overlapping syndromes and geography,
based on and updated from that review are depicted in Fig 1.
Database construction
For retrospective patient analysis, a database was created by integrating data from the two
arbovirus diagnostic reference centers in the Netherlands: Erasmus Medical Centre in Rotter-
dam and The National Institute for Public Health and the Environment in Bilthoven. Previ-
ously, we described trends of DENV diagnostics in the Netherlands from 2000–2010.[12] The
current study included almost all arbovirus diagnostic requests from Dutch physicians from
2009 through 2013 in the Netherlands. In the case of DENV not all data was included because
10% of the DENV diagnostics were performed outside the arbovirus reference centers and
were not included in this dataset. For syndromic analysis, only entries were included where
travel and clinical history were provided. To define the syndromes, entries in the database were
reviewed by a consultant microbiologist, and infectious disease clinicians assigned them to syn-
drome categories (Table 1).
Patient test result classification
Due to the laboratory-specific variety in diagnostic methods used, we classified each patient’s
test results according to the validated methods and cut-offs for the pertinent laboratory. Results
were classified as positive for a disease if the patient had (1) a positive PCR result with<40
cycles, (2) an IgM above an individual laboratory-determined cut-off, or (3) a minimum four-
fold increase in IgG titers between two consecutive samples. For DENV patients, (4) a positive
non-structural protein 1(NSI) antigen-capture test was among the criteria.[6]
Analysis of the likelihood of arboviral infections in travelers
The likelihood of infections by arboviruses other than DENV was based on a previously pub-
lished article in which we developed syndromic diagnostic algorithms based on data from an
exhaustive review of the literature addressing geographic distribution and prevalence of arbovi-
ruses by syndrome.[12] Optimal diagnostic algorithms using a combination of clinical syn-
dromes and geographical distribution presented were updated and used as a basis for our
current analysis (Fig 1). In short, criteria used to prioritize arboviruses for the diagnostic algo-
rithm were: a) circulation in urbanized areas, due to the use of humans as reservoir hosts, or
the presence of reservoir hosts colonizing urban areas, b) known endemic disease, c) tourist
activity in the area, d) high rate of exposure in resident population, and e) recorded cases of
infections in travelers.[4] These diagnostic algorithms were used in the current article to iden-
tify gaps that may occur with a physician-indexed single-virus approach.
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Travel data
Travel data for Dutch travelers was based on the year 2011. They were extracted from a com-
mercial database “ContinuVakantieOnderzoek” (CVO) created for trend analysis in the tour-
ism industry. Its data are collected and converted into national numbers every three months by
interviewing individuals in about 15,000 Dutch households on their travel destinations, activi-
ties, lodging, transport, and booking method.[13] Using data from 2011 provided a representa-
tive distribution of Dutch travel behavior from 2009–2011. Only slight country specific
fluctuations were reported.[13]
Statistical analysis
The analysis was performed in STATA.[14] Pearson's chi-square test was used to assess for
equality of proportions. Multivariable logistic regression models (Table 2) reporting odds ratios
Fig 1. Geographical distribution of medically important arboviruses that cause febrile disease in humans. All arboviruses cause febrile symptoms,
but symptomsmore specific to certain viruses are represented in three columns: 1) Arthralgia-Rash (AR); 2) Neurological symptoms (NS), and 3)
Hemorrhagic symptoms (HS). Arboviruses not known to cause more than febrile symptoms are preceded with a §-sign. Arboviruses more likely to be
diagnosed in travelers are followed by *. DENV^ is a serocomplex encompassing multiple dengue viruses that can cause similar clinical disease in humans.
For viruses in gray type, diagnostics are unavailable in the Netherlands but in most cases can tested through the European Network for Imported Viral
Diseases (ENVID). Geographical regions based on UN definitions of world regions. EU, Sub-Saharan Africa and South & Southeast Asia regions are
grouped in these representations for visual clarity but are subdivided according to UN definitions for analysis as can been seen in Figs 3–6. AR = arthralgia-
rash; NS = neurological symptoms; HS = hemorrhagic symptoms; AKHV = Alkhurma hemorrhagic fever virus; BANV = Banna virus; BFV = Barmah Forest
virus; BWAV = Bwamba virus; BUNV = Bunyamwera virus; CEV = California encephalitis virus; CHIKV = Chikungunya virus; CTFV = Colorado tick fever
virus; CCHFV = Crimean-Congo hemorrhagic fever; DENV = Dengue virus; EEEV = Eastern equine encephalitis virus; GROV = Guaroa virus; ILEV = Ilesha
virus; ILHV = Ilheus virus; JEV = Japanese encephalitis virus; KFDV = Kyasanur Forest disease virus; LCV = La cross virus; LIV = Louping Ill virus;
MAYV = Mayaro virus; MURV = Murray Valley virus; NRIV = Ngari virus; OHFV = Omsk hemorrhagic fever virus; ONNV = O’Nyong Nyong virus;
OROV = Oropouche virus; RVFV = Rift Valley fever virus; ROCV = Rocio virus; RRV = Ross river virus; SFV = Sandfly fever (Naples / Sicilian / other); SFTS
V = Severe Fever with Thrombocytopenia Syndrome Virus; SINV = Sindbis virus; SLEV = St. Louis encephalitis virus; TAHV = Tahyna virus;
TATV = Tataguine virus; TBEV = Tick-borne encephalitis virus; TOSV = Toscana virus; VEEV = Venezuelan equine encephalitis virus; WEEV =Western
equine encephalitis virus; WNV =West Nile virus; YFV = Yellow fever virus; ZIKV = Zika virus.
doi:10.1371/journal.pntd.0004073.g001
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were used with a 95% confidence level.[14] Heatmaps were generated using the additional R
package “stats”[15] and based on pair-wise correlation between rows and columns.
Ethical statement
This research was conducted in accordance with the Dutch law on medical research (WMO),
article 1. In compliance with Dutch Law and medical ethical guidelines, no personal identifiers
were included and no informed consent was required for use of data in this study.
Results
General dataset
Over the five year study period 8126 patients were tested for arboviral diseases in the Nether-
lands. Of the patients, 44% presented to larger hospitals or specialized travel clinics. All other
patients were seen at smaller hospitals or local clinics. Molecular tests comprised 1.3% of diag-
nostic tests performed. Larger hospitals and specialized travel/tropical clinics tested on average
for 1.7 viruses per patient compared to 1.2 in smaller hospitals and local clinics. The patient
male to female ratio was 1.04. Vaccination history was recorded on the diagnostic request for
only 14 patients (<1%).
Of all patients, 2153 (26%) had information on travel history and clinical history and were
thus included for further syndrome and travel-based analysis. Of these, 23% had provided a
second serum sample needed for determination of a potential IgG titer increase. With a median
Table 1. Clinical manifestations classified per syndrome used for search in diagnostic database. Search was based on approximation of listed terms
in multiple languages.
Syndrome Respiratory Enteric Febrile Neurological Skin Rheumatic Hemorrhagic
Symptoms Throat ache Diarrhea Fever Glasgow coma
scale
Rash Rheumatic
pain
Secondary/ primary
hemostasis
Coughing Vomiting Pyrexia Coma Exanthema Joint pain Hematemesis
Wheezing Dehydration Febrile Reduced
responsiveness
Spots Arthralgia Hemoptysis
Hoarseness Nausea Temperature Epileptic symptoms Erythema Arthritis Melena
Nasal / ocular
discharge
Gastroenteritis Malaise Encephalitis Maculopuritis Vasculitis Hemorrhagic diatheses
Bronchitis Abdominal
pain
Flu-like
symptoms
Meningitis Thrombocytopenia
Pneumonia Myelitis Petechial
Rhinitis Ataxia Ecchymosis
Hypoxia Paresis Anemia
Dyspnea Flaccid paralysis DIC (diffuse intra-vascular
coagulation)
Apnea Neurological
symptoms
Reduced clotting
Pleural effusion Neurological
dysfunction
Reduced platelet count
Chest congestion Neurological
disease
Earache Polyradiculitis
Otalgia
Sinusitis
Epiglottitis
doi:10.1371/journal.pntd.0004073.t001
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of 7 days, the average number of days elapsed between onset of symptoms and first sampling
was 17.5 (95%CI 14.0–20.3). This number is based on the 317 patients with clinical and travel
history for whom this chronological information was recorded. Elapsed time did not differ
between patients seen at specialized hospitals/clinics and those visiting smaller hospitals/
clinics.
Comparison travel destination
We analyzed the travel data of Dutch travelers in 2011 to determine the range and importance
of arbovirus tests needed to cover the differential diagnosis for travelers with illness after return
from the various destinations. In 2011, approximately 84% of Dutch travelers traveling abroad
stayed within Europe. Western Asia (predominantly Turkey) was the most popular non-Euro-
pean destination, with nearly one million Dutch vacations booked annually (Fig 2).[13] The
most diagnostic requests (35%) by far, however, were for travelers returning from destinations
in South and Southeast Asia, while only 3% of all travelers had this region as their destination.
Diagnostic requests and outcomes per region
The number of diagnostic requests by travel region and the proportion of positive test results
(Fig 2) show that DENV testing was by far the most commonly requested (86%), yielding the
highest absolute number of cases (Fig 2). When comparing the numbers of requests and pro-
portions of positives by region of travel, substantial differences were observed: diagnostic
requests for ill travelers returning from sub-Saharan Africa were frequent but not often posi-
tive, whereas ill travelers returning from popular arbovirus-endemic regions in Central and
Table 2. Adjusted odds ratios of statistically significant predictive syndromes for a positive test outcome. The test is stated in column 1, with corre-
sponding variables in column 2. Variables were adjusted for age, sex, travel region, and diagnostic laboratory.
Dependent variable Independent
Variable
Adjusted Odds
ratio
95% CI P-
value
DENV-positive versus negative test outcome (based on 1843 patients with DENV-
diagnostic tests performed)
Febrile symptoms 2.0 1.2–3.0 <0.01
Rash 1.9 1.3–2.5 <0.01
Arthralgia-arthritis 0.5 0.3–0.8 <0.01
Hemorrhagic
symptoms
2.8 1.8–4.5 <0.01
Neurological
symptoms
0.7 0.2–1.9 0.4
Respiratory
symptoms
0.5 0.3–0.8 <0.01
Enteric symptoms 0.8 0.5–1.1 0.1
CHIKV-positive versus negative test outcome (based on 736 patients with CHIKV-
diagnostic tests performed)
Febrile symptoms 1.5 0.7–3.2 0.3
Rash 4.0 2.2–7.1 <0.01
Arthralgia-arthritis 2.9 1.7–5.2 <0.01
Hemorrhagic
symptoms
0.4 0.1–3.4 0.4
Neurological
symptoms
0.7 0.1–6.2 0.7
Respiratory
symptoms
0.3 0.1–1.1 0.1
Enteric symptoms 0.4 0.1–1.1 0.1
doi:10.1371/journal.pntd.0004073.t002
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Western Asia were rarely tested. A low number of patients who had traveled within Europe
were tested. DENV was tested (N = 41) almost as often as tick-borne encephalitis virus (TBEV)
(N = 57), for which exposure is far more likely. Of note, two of these European travelers tested
DENV-positive. One was a tourist returning from Croatia, who tested DENV-IgM-positive
and borderline NS1-positive. The other tourist had taken a five-day trip to Southern France
and was DENV IgM- and NS1-positive 10 days after return. However, 14 days previous to
onset of symptoms, this traveler had been in Thailand before traveling on to France. Another
virus considered endemic to Europe is Sindbis virus (SINV), for which diagnostics are not
readily available in the Netherlands. Nor are they available for oropouche virus (OROV),
endemic to South America.
Syndromes reported
To assess the potential use of diagnostic requests for syndrome surveillance by region, we ana-
lyzed the symptoms recorded for each patient returning from a particular travel destination.
Nearly all patients (86%) reported fever, followed by arthralgia/arthritis (22%) and enteric
symptoms (14%). Information divided per travel region showed regional variation in symp-
toms recorded (Fig 3). For all regions, fever was the most reported symptom. Proportionally,
Fig 2. Geographical depiction of the number of diagnostic tests requested after travel to each region (see gray shading and tables) from 2009 to
2013. Boxes show number and percentage of all vacations booked from the Netherlands to each region in 2011.
doi:10.1371/journal.pntd.0004073.g002
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neurological symptoms were more often reported for travelers returning from a European des-
tination than for travelers from other regions. Arthralgia-arthritis was recorded more fre-
quently for travelers returning from Oceania, with rash being most recorded for Southern
Africa compared to other regions.
Comparing diagnostic requests to diagnostic algorithms
Three heatmaps were created to visualize per continent (Africa, Asia and the Americas) the
correlation between the physicians’ diagnostic requests and the literature-based syndromic
algorithms (Fig 1). In the heatmaps, diagnostic requests are grouped based on the clinically
important arboviral diseases per region within each continent (Figs 4–6). For most regions,
Dutch physicians requested DENV diagnostics for 100% of the travelers who had recorded
symptoms corresponding to DENV infection (fever, rash and joint pain). For some regions, a
lower percentage of such patients was tested, i.e. Northern Africa (67%) (Fig 4), Western Asia
(57%) (Fig 5) and Central America (38%) (Fig 6). In all regions, CHIKV testing was less fre-
quently requested than DENV testing, even though the infections overlap in geographical
Fig 3. Percentage of patients (left axis) with arbovirus diagnostic requests presenting with symptoms by travel destination (horizontal axis). The
number of patients per group is shown in parentheses on the horizontal axis (based on 2153 patients with both travel and clinical history).
doi:10.1371/journal.pntd.0004073.g003
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distribution and range of symptoms to a great extent. On average, 45% of patients with febrile
symptoms, rash and/or arthralgia after travel to CHIKV-risk areas in Asia were not tested for
CHIKV. Patients with symptoms suggesting West Nile Virus (WNV), Japanese encephalitis
(JEV), Rift Valley fever virus (RVFV) and TBEV were tested infrequently (0 to 25%) and only
in association with neurological symptoms. Diagnostics on all other viruses presented in Figs
4–6 were minimally requested.
Predictive factors for positive tests
We analyzed the association between symptoms recorded and test outcomes for DENV and
CHIKV requests in Dutch travelers (Table 2). Patients with rash, hemorrhagic symptoms and
fever had an increased odds of testing positive for DENV, but respiratory symptoms decreased
the odds of being DENV-positive (OR 05). Positive test outcomes for CHIKV were associated
with arthralgia combined with rash. Both DENV and CHIKV were positively associated with
travel history to Southeast Asia.
Fig 4. Heatmapsshowing percentage of patients with a travel history to Africa, divided by region (right axis) and recorded symptoms (left axis),
who were tested for each arbovirus (horizontal axes) posing a risk on that continent (see Fig 1). The number of patients in each region-symptom
combination follows each region in parentheses, far right. Groups in which a 100% of patients with a specific region-symptom combination were tested are
depicted as black, with a sliding scale to white for groups in which 0% of patients were tested. Region-symptom combinations that are atypical for a certain
arbovirus are depicted as diagonal lines.
doi:10.1371/journal.pntd.0004073.g004
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Discussion
Here we assessed the extent of missed arboviral infections in travelers by a retrospective data-
base analysis of all arboviral diagnostic requests in the Netherlands, from 2009–2013, in com-
parison with a literature-based assessment of arbovirus exposure while traveling (Fig 1). We
found clear evidence for patient groups high at risk of being under-diagnosed for arboviral dis-
ease when evaluated by syndrome and by region. While DENV diagnostics are routinely
requested, other relevant arboviruses are neglected, in particular CHIKV. Arthralgia, for exam-
ple, is not only associated with DENV infections but also with many arboviruses, including
CHIKV, as we found when calculating odds ratios within the current Dutch data.[4] Neverthe-
less, less than 55% of patients with symptoms compatible with CHIKV infection were tested
(Fig 4a–4c). Interestingly, hemorrhagic symptoms and rash have a much higher odds ratio
than arthralgia-arthritis for diagnosing DENV. Although arthralgia is an important symptom
in dengue patients, rash and fever are often more pronounced.[16] In the case CHIKV arthral-
gia-arthritis is more pronounced and is known to have a higher predictive value for distin-
guishing CHIKV from DENV in endemic settings.[16, 17] Additionally, CHIKV is less well
known by physicians in non-endemic countries so might be only considered if DENV diagnos-
tics are negative.
Fig 5. Heatmap showing percentage of patients with a travel history to Asia, divided by region (right axis) and recorded symptoms (left axis), who
were tested for each arbovirus (horizontal axes) posing a risk on that continent (see Fig 1). The number of patients in each region-symptom
combination follows each region in parentheses, far right. Groups in which a 100% of patients with a specific region-symptom combination were tested are
depicted as black, with a sliding scale to white for groups in which 0% of patients were tested. Region-symptom combinations that are atypical for a certain
arbovirus are depicted as diagonal lines.
doi:10.1371/journal.pntd.0004073.g005
Syndromic Approach to Arboviral Diagnostics for Travelers
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004073 September 15, 2015 10 / 15
The analysis of diagnostic requests by region showed a bias toward the more well-known
arboviral risk areas such as Southeast Asia (Figs 2 and 3). For travelers within Europe, arbovi-
rus diagnostics are rarely requested, despite high incidence rates of TBEV reported across
Europe and continuing circulation of WNV in parts of Europe popular with Dutch tourists.[8,
18] This is a general trend also seen in previous reports on travel associated infection present-
ing in Europe.[19] Housing type and location during travel is an import risk factor for exposure
to specific vectors,[20, 21] and outdoor camping is popular among travelers in Europe.[13]
The number of CHIKV and DENV requests within Europe was almost equivalent to the num-
ber of TBEV and WNV test requests, while only a small number of CHIKV and DENV have
been reported.[22–24] The low number of TBEV and WNV requests may reflect a lack of phy-
sician awareness of European arboviruses and their risk to travelers; it may also reflect financial
restrictions or limited time.[18]
Our analysis showed that physicians were more likely to extend the diagnostic panel for
patients with more severe or very specific symptoms. For instance, diagnostics for WNV and
Western equine encephalitis virus (WEEV) were usually requested only for patients with neu-
rological complaints, even though fever is the most common clinical presentation in>90% of
WNV andWEEV patients.[25] Similarly, RVFV diagnostic requests were limited to patients
Fig 6. Heatmap showing percentage of patients with a travel history to Americas, divided by region (right axis) and recorded symptoms (left axis),
who were tested for each arbovirus (horizontal axes) posing a risk on that continent (see Fig 1). The number of patients in each region-symptom
combination follows each region in parentheses, far right. Groups in which a 100% of patients with a specific region-symptom combination were tested are
depicted as black, with a sliding scale to white for groups in which 0% of patients were tested. Region-symptom combinations that are atypical for a certain
arbovirus are depicted as diagonal lines.
doi:10.1371/journal.pntd.0004073.g006
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with hemorrhagic symptoms (HS) and neurological symptoms (NS), although these severe
symptoms occur in less than 1% of cases, and most patients present only with febrile symptoms
(Fig 4a–4c).[26] This bias toward severe symptoms was likewise reflected by the finding that
patients referred to large hospitals and travel clinics were more extensively evaluated than
those visiting small hospitals and local clinics. Reasons for this difference were not assessed in
our study but are likely related to the fact that 1) general practitioners often omit arbovirus
diagnostics, due in part to budgetary constraints; 2) they may lack knowledge on arboviral dis-
ease, and 3) may believe that an arbovirus diagnosis is unlikely to influence their treatment
decisions, particularly if symptoms are mild. However, even mild arbovirus infections can
eventually cause severe or chronic symptoms like arthralgia and, in any case, they pose a poten-
tial risk to health workers. Lack of proper diagnosis may lead to unnecessary complications or
extensive later testing of patients. A possible solution to this problem is diagnostic centers pro-
viding syndromic and region based diagnostic packages for travelers as presented by the algo-
rithms here.[4] These can be continuously updated in collaboration with specialized physicians
and Public Health professionals. This will relieve the general physicians from keeping up to
date on such a complex and continuously changing area. At the same time physicians are pro-
vided with a complete diagnostic selection and data are more suitable for use in surveillance.
Our results show a large variation in the timing of first diagnostic sampling. In our study,
50% of travelers contacted a healthcare provider during the first week of illness. This means
that 50% did not, and viremic patients may introduce viruses into a region, when appropriate
vectors are available, [23, 27] or pose a risk for nosocomial infection.[28, 29] Only 1.3% of all
diagnostic tests performed were molecular, while 50% of patients fell within the range advised
for molecular testing. The timeframe for molecular and serological diagnostics overlap to a
great extent. Within the first days of illness, however, serology has a low sensitivity.[6] A num-
ber of the DENV cases may have been secondary, tertiary or quaternary infections. This
reduces the sensitivity of serological detection by IgM in non-primary infections significantly.
[6] Many patients are therefore probably missed due to lack of molecular testing within this
timeframe. To use diagnostic data for syndromic surveillance, a two-tiered approach could be
employed. First, samples collected after three days of illness onset would provide syndromic
information by multiplex serologic testing. Second, if testing showed increased circulation of a
target virus, confirmation and genomic surveillance would follow in patients suspected to har-
bor that virus sampled within seven days of illness.
There are a number of limitations to this study. Nearly all patients tested for arboviral dis-
eases in the five-year-period in the Netherlands were included. This group, however, only con-
sists of patients that seek medical attention after travel and that are suspected of an arboviral
infection by a clinician. Asymptomatic patients and patients where clinicians did not consider
an arboviral disease are missed. Almost all patients lack vaccination history. Patients with
recent yellow fever vaccinations could cause positive false positive serological tests.[6] Lack in
reporting vaccination history and the resulting possible flavivirus cross-reactivity due to vacci-
nation are known problems when using flavivirus serological diagnostic data.[9] Both diagnos-
tic centers had extensively validated tests internally with yellow fever vaccines and changed
diagnostic cut-offs provided by manufacturer to compensate if possible. However, false positive
tests due to vaccination cannot be excluded.
Infectious disease diagnostics and surveillance of travelers is primarily focused on those
cases or diagnostic outcomes selected and reported by physicians.[30–33] Although this
approach provides essential information, many patients remain undiagnosed, and re-evalua-
tion of the selected pathogens has been advised.[10, 31, 34] However, much knowledge on
probable arbovirus exposure of travelers is based on information originating from the destina-
tion country, which may have limited surveillance and diagnostic capabilities. In some of these
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countries, large-scale surveillance projects using a more syndromic approach to infectious dis-
eases have shown extensive under-diagnosis and under-recognition of the importance of many
arbovirus diseases as a cause of common syndromes.[35, 36] This underlines the need, in the
Netherlands and other affluent countries, for more systematic syndrome-based diagnosis and
surveillance in travelers to these regions. It demonstrates the added value of using routine
travel information to support national and international surveillance programs. For such sur-
veillance, capturing only a fraction of all cases may still provide reliable information on disease
trends and possibly local outbreaks, provided the selection is systematic.[9] It is also important
in terms of preparedness for emerging infectious diseases.
Conclusion
A physician’s diagnostic requests for returned travelers can play a key role in infectious disease
surveillance. However, while travel destination and syndrome could be used for triage and
diagnostics, such use is inconsistent. We found clear evidence of patient groups at risk of
under-diagnosis of arboviral disease when evaluated by syndrome and by region.
Based on a comparison between all arboviral diagnostic requests by physicians in the Neth-
erlands between 2009 and 2013 with a literature-based assessment of the likely exposure of the
patients to an arbovirus, we showed that while dengue virus diagnostics are routinely
requested, other relevant arboviruses such as chikungunya virus are neglected, even if travelers
present with relevant symptoms and return from countries where the viruses are endemic. We
also showed that for travelers to European destinations, arbovirus diagnostics were rarely
requested and that for almost all arboviruses and travel destinations, diagnostics were
requested only when patients presented with severe symptoms.
Whether the low number of requests and overemphasis of physicians on patients presenting
with severe symptoms reflects a lack of physician awareness of arboviruses and their risk to
travelers, financial restrictions or limited time, it points at possible gaps in preparedness. Our
paper shows that in order to limit the amount of missed clinical arboviral infections, and to
increase the level of awareness of arboviral infections of public health significance, physicians
should rely on diagnostics and surveillance with a syndromic approach and matching labora-
tory methods.
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